NCT05555784View on ClinicalTrials.gov

Evaluation of Impact of Disease and Visual Disability on Quality of Life and Loss of Independence of Patients Living in France With Leber's Hereditary Optic Neuropathy (LHON) Through Qualitative and Quantitative Data Collection

CompletedOBSERVATIONAL
Enrollment

12

Participants

Timeline

Start Date

August 4, 2022

Primary Completion Date

February 2, 2023

Study Completion Date

February 2, 2023

Conditions
Leber's Hereditary Optic Neuropathy (LHON)
Trial Locations (1)

45160

Argo Sante, Orléans

Sponsors

Collaborators (1)

GenSight Biologics
All Listed Sponsors
collaborator

GenSight Biologics

INDUSTRY

lead

Argo Sante

OTHER

NCT05555784 - Evaluation of Impact of Disease and Visual Disability on Quality of Life and Loss of Independence of Patients Living in France With Leber's Hereditary Optic Neuropathy (LHON) Through Qualitative and Quantitative Data Collection | Biotech Hunter | Biotech Hunter